Fasting plasma glucose, HbA1c linked to alzheimer's in T2DM

July 25, 2017

(HealthDay)—For patients with type 2 diabetes mellitus (T2DM), fasting plasma glucose (FPG) visit-to-visit variation, represented by the coefficient of variation (CV), and hemoglobin A1c (HbA1c) CV are independently associated with Alzheimer's disease (AD), according to a study published online July 13 in Diabetes Care.

Tsai-Chung Li, Ph.D., from China Medical University in Taiwan, and colleagues included 16,706 patients with T2DM in the National Diabetes Care Management Program who were age 60 years or more and without diagnosis of AD. The authors sought to examine the correlation between glycemic variability and incidence of AD.

The researchers identified 831 incident cases of AD during a median follow-up of 8.88 years, with a crude incidence rate of 3.5/1,000 person-years. Both FPG CV and HbA1c CV were significant predictors of AD after adjustment for sociodemographic factors, lifestyle behaviors, diabetes-related variables, FPG and HbA1c, drug-related variables, and comorbidities, with hazard ratios of 1.27 and 1.32 for the third tertiles of FPG CV and HbA1c CV, respectively.

"The associations between glycemic variability and AD demonstrated in this study suggest a linked pathophysiological mechanism, which is worthy of further investigation," the authors write.

Explore further: Visceral/subcutaneous fat ratio predicts CVD in T2DM

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Visceral/subcutaneous fat ratio predicts CVD in T2DM

July 21, 2017
(HealthDay)—For patients with type 2 diabetes, the ratio of visceral fat area (VFA) to subcutaneous fat area (SFA) (V/S ratio) is predictive of cardiovascular disease (CVD), according to a study published online July 7 ...

Continuous subcutaneous insulin infusion bests injections in T2DM

April 7, 2017
(HealthDay)—For patients with type 2 diabetes and hemoglobin A1c (HbA1c) >8 percent following multiple daily injections (MDI), continuous subcutaneous insulin infusion (CSII) is associated with a significantly greater reduction ...

Postprandial hyperglycemia linked to CVD incidence in T2DM

December 28, 2016
(HealthDay)—For patients with type 2 diabetes, postprandial hyperglycemia is associated with incidence of cardiovascular disease (CVD) and all-cause mortality, independently of the mean glycated hemoglobin (HbA1c) level, ...

Lower HbA1c linked to better diabetes-specific HRQoL in youth

June 6, 2017
(HealthDay)—For children, teens, and young adults with type 1 diabetes mellitus (T1DM), hemoglobin A1c (HbA1c) is associated with better diabetes-specific health-related quality of life (D-HRQoL), according to a study published ...

Follow-up phone calls may boost glycemic control in T2DM

November 19, 2016
(HealthDay)—For patients with type 2 diabetes, follow-up phone calls after a monthly clinic visit could lead to clinically significant change in hemoglobin A1C (HbA1c) levels, according to a study published online Nov. ...

Early glycemic control with metformin cuts CVD events

April 22, 2017
(HealthDay)—For patients with type 2 diabetes who initiate metformin, early achievement of low hemoglobin A1c (HbA1c) is associated with a reduction in the subsequent risk of cardiovascular events or death, according to ...

Recommended for you

Gut protein mutations shield against spikes in glucose

November 20, 2018
Why is it that, despite consuming the same number of calories, sodium and sugar, some people face little risk of diabetes or obesity while others are at higher risk? A new study by investigators at Brigham and Women's Hospital ...

Can't exercise? A hot bath may help improve inflammation, metabolism, study suggests

November 14, 2018
Hot water treatment may help improve inflammation and blood sugar (glucose) levels in people who are unable to exercise, according to a new study. The findings are published ahead of print in the Journal of Applied Physiology.

Diabetic foot ulcers heal quickly with nitric oxide technology

November 12, 2018
Diabetic foot ulcers can take up to 150 days to heal. A biomedical engineering team wants to reduce it to 21 days.

Diabetes drug might also ease heart failure risks

November 12, 2018
(HealthDay)—The diabetes drug Farxiga might do double-duty for patients, helping to ward off another killer, heart failure, new research shows.

Marijuana use tied to serious diabetes complication

November 8, 2018
(HealthDay)—People with type 1 diabetes who use marijuana may double their risk of developing a life-threatening complication, a new study suggests.

Researchers report connection between intestinal bacteria and development of diabetes

November 7, 2018
Researchers at Örebro University have, together with a well-known research team in Denmark, developed a method for studying how metabolism in gut bacteria influences health. Their method will now be published in its entirety ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.